Gilead Sciences (NASDAQ:GILD) is scheduled to announce Q3 earnings results on Thursday, October 24th, after market close.
The consensus EPS Estimate is $1.73 (-6.0% Y/Y) and the consensus Revenue Estimate is $5.61B (+0.2% Y/Y).
Over the last 2 years, GILD has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
Over the last 3 months, EPS estimates have seen 12 upward revisions and 8 downward. Revenue estimates have seen 13 upward revisions and 8 downward.
https://seekingalpha.com/news/3508507-gilead-sciences-q3-2019-earnings-preview
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.